Markus Rentsch
Papers
3
Total Citations
87
H-Index
2
About
Markus Rentsch is a leading figure in the field of interventional oncology, with a specific focus on the treatment of liver metastases. His research centers on the comparative efficacy of minimally invasive and non-invasive salvage therapies for patients with non-resectable tumors. Rentsch’s major contribution lies in his pioneering work evaluating robotic radiosurgery (RRS) against established techniques like percutaneous radiofrequency ablation (RFA). His landmark 2013 study, cited over 56 times, provided critical data on the outcomes of these two modalities in heavily pretreated patients with colorectal liver metastases, offering new hope for those with limited options. By demonstrating the value of the CyberKnife® robotic radiosurgical device, he helped establish stereotactic radiation as a viable, non-invasive alternative to thermal ablation. His work has been instrumental in expanding the therapeutic arsenal for liver tumors, directly impacting clinical decision-making for patients who cannot undergo surgery. Through his comparative analyses, Rentsch has significantly advanced the understanding of how to optimize local tumor control while minimizing procedural invasiveness.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3